Once oral dialysis drugs like Amgen's Sensipar, used to treat hyperparathyroidism, are included in the dialysis payment bundle, it is unlikely that the inevitable drop in sales will match what the biotech firm has seen from its anemia drugs.
This new bi-weekly summary is intended to highlight the important stories from and about the kidney care community and offer a place to analyze and discuss them, as well as dive deeper into some of the issues we are covering on our website and in the pages of our magazine.
Despite overwhelming evidence that extending coverage would save lives, donated kidneys, and money, policymakers remain, according to a new perspective piece in The New England Journal of Medicine, penny wise and pound foolish.
Busy Maryland nephrology practice looking for part time physician to join 6 person group in Maryland. Opportunity for office based practice, outpatient dialysis and hospital consults. Competitive salary and flexible ...More